Improved insulin sensitivity, lipid profile, and redistribution of body fat induced by berberine offer a promising future prospect to prevent cardiovascular disease and metabolic syndrome in patients with PCOS [15]. The gene discussed is INS; the disease is polycystic ovary syndrome.